"Soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis and reflects joint damage over time."

Reumadagarna 2018. Helena Enocsson, PhD Linköpings Universitetssjukhus, berättar om forskningen, "Soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis".